Upcoming Events
Search Result For "Antibody".
- Event Type
- Event Category
- Event Country
- Event Date
Event Type
Categories
Country
City
Date
Prioritizing Back Translation from Bedside to Bench and Novel Targets With a whopping 7 approvals in the last two years, the field is alive with p...
Engineering Safety and Developability for Complex Antibody-Based Therapeutics. The Antibody and Fusion Protein Engineering and Developability Su...
The year 2024 has been considered the 'coming of age' era for antibody-drug conjugates, in great part due to the remarkable resurgence in drug deve...
Toxicities continue to pose the most significant challenge in the progression of antibody-drug conjugates to the clinic, and with increasing compan...
Gamma Delta T cells prove an exciting platform for the treatment of solid tumor indications and autoimmune disorders. The unique biology of these c...
As of 2023, more than 10 bispecific antibodies have been successfully approved by the FDA, and more than 100 are currently in clinical trials, high...
Creative Biolabs has invited Dr. James Naismith to walk us through the development of his novel SARS-CoV-2 neutralizing sdAbs and how his team has ...
With numerous novel conjugate companies recently receiving their INDs to enter the clinic including Avidity Biosciences and Dyne Therapeutics and m...
The 13th World ADC London returns in 2023 as Europe's longest standing and definitive antibody-drug conjugate event - and it's back bigger and bett...
The TCE pipeline is ever-growing and there are multiple different formats, engagers and costimulatory being studied in over 90 trials, with over a ...
There is a vast number of ADCs that never make it to the clinic let alone to market, and this is largely due to toxicological challenges providing ...
As the proportion of clinically site-specific ADCs increases, the abundance of novel conjugation technologies diversifies, and the linker chemistry...